Axena Health

Coming – December 2

Transforming a $1 Billion Women's Health Market

Date and Time

December 2

–

4:00 PM ET / 1:00 PM PT

Details will be shared with confirmed attendees

About this Event

28 million American women experience moderate-to-severe urinary incontinence, yet fewer than 7% receive recommended first-line treatment. Axena Health is addressing this enormous unmet need with an FDA-cleared, clinically proven technology designed to make effective treatment accessible, convenient, and affordable.

Join us for an Executive Briefing with Axena Health’s leadership to discover how this commercial-stage women’s healthcare company is transforming pelvic health with its Leva® Pelvic Health System, a prescription, at-home treatment requiring just five minutes of daily therapy.

Axena combines strong clinical evidence with growing commercial traction and an expanding platform:
  • Large Market Opportunity: Approximately $1 billion annually in the U.S. for urinary incontinence treatment.
  • Proven Clinical Results: Peer-reviewed studies demonstrate significant symptom improvement, with benefits sustained for up to two years.
  • Commercial Momentum: $3.8 million in 2025 revenue, with management forecasting approximately $6.6 million in 2026.
  • Expanding Market Access: Approximately 50 million covered lives through growing insurance reimbursement.
  • Strategic Collaboration: Working with Mayo Clinic on clinical integration, AI-enabled precision care, and future product development.

At the center of the discussion is Trethera’s first-in-class drug candidate, TRE-515, designed to selectively inhibit an enzyme involved in the proliferation of disease-causing cells. Early research suggests the potential to suppress abnormal immune activity while preserving healthy immune function, an approach that could have important implications for diseases ranging from multiple sclerosis and optic neuritis to certain cancers.

Register today to discover how Axena is combining clinical innovation, commercial execution, and expanding reimbursement to address one of women’s healthcare’s largest underserved markets.

Sign Up Today

SHARE THIS EVENT

This presentation contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts and referenced statistics, contained in this presentation, including statements regarding future company strategy, operations, financial position, revenues, projected costs, plans and objectives of management, will be forward-looking statements.

All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.